Long-term probucol therapy continues to suppress markers of neurovascular inflammation in a dietary induced model of cerebral capillary dysfunction

Lipids in Health and Disease

John CL Mamo¹  Corey Giles¹  Virginie Lam¹  Ryusuke Takechi¹ 

[1] School of Public Health, and CHIRI Biosciences Research Precinct, Faculty of Health Sciences, Curtin University, Bentley, GPO Box U1987, Perth 6845, WA, Australia

关键词: Saturated fatty acids;    Probucol;    Neuroinflammation;    Enterocytes;    Blood–brain barrier;    Apolipoprotein B;    Amyloid-β;    Brain capillaries;   

Others  :  801169
DOI  :  10.1186/1476-511X-13-91

 received in 2014-05-07, accepted in 2014-05-28,  发布年份 2014

【 摘 要 】

Background

Probucol has been shown to prevent cerebral capillary disturbances characterized by blood-to-brain extravasation of plasma derived proteins and neurovascular inflammation in mice maintained on western-styled diets for 12 weeks. However the effect of probucol on capillary integrity in aging models with capillary dysfunction is not known.

Methods

Wild-type C57BL6 mice were randomized to a low-fat (LF); saturated-fat (SFA); or SFA + Probucol diet for up to12 months of intervention.

Results

Mice fed the LF diet had substantially greater parenchymal abundance of plasma derived IgG and apo B lipoproteins at 12 months, compared to LF mice at 3 months of intervention. Markers of neurovascular inflammation were also greater at 12 months in LF fed mice compared to LF mice at 3 months. The SFA diet exacerbated the aging induced parenchymal abundance of IgG and of apo B lipoproteins and neurovascular inflammation at 12 months. The SFA effects were associated with increased production of intestinal lipoprotein amyloid-β (Aβ). The co-provision of probucol with the SFA completely abolished heightened inflammation at 12 months. Probucol attenuated SFA-induced capillary permeability but had only a modest inhibitory effect on parenchymal retention of apoB lipoproteins. The improvements in markers of inflammation and capillary integrity because of probucol correlated with enterocytic genesis of chylomicron Aβ.

Conclusion

In this long-term feeding study, probucol profoundly suppressed dietary SFA induced disturbances in capillary integrity but had a more modest effect on age-associated changes.

【 授权许可】

   
2014 Takechi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Santos DB, Peres KC, Ribeiro RP, Colle D, dos Santos AA, Moreira EL, Souza DO, Figueiredo CP, Farina M: Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid beta peptide in mice. Exp Neurol 2012, 233:767-775.
• [2]Poirier J: Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer’s disease. Alzheimers Dement 2008, 4:S91-S97.
• [3]Poirier J: Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer’s disease. Trends Mol Med 2003, 9:94-101.
• [4]Takechi R, Galloway S, Pallebage-Gamarallage MM, Lam V, Dhaliwal SS, Mamo JC: Probucol prevents blood–brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding. Clin Exp Pharmacol Physiol 2013, 40:45-52.
• [5]Takechi R, Galloway S, Pallebage-Gamarallage MM, Wellington CL, Johnsen RD, Dhaliwal SS, Mamo JC: Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta. Br J Nutr 2010, 103:652-662.
• [6]Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC: Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood–brain barrier function in wild-type mice. J Neuroinflam 2013, 10:73. BioMed Central Full Text
• [7]Pallebage-Gamarallage MM, Galloway S, Takechi R, Dhaliwal S, Mamo JC: Probucol suppresses enterocytic accumulation of amyloid-beta induced by saturated fat and cholesterol feeding. Lipids 2012, 47:27-34.
• [8]Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC: Aging-related changes in blood–brain barrier integrity and the effect of dietary fat. Neurodegener Dis 2013, 12:125-135.
• [9]Pallebage-Gamarallage MM, Takechi R, Lam V, Galloway S, Dhaliwal S, Mamo JC: Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: implications for dementia risk. Atheroscler Suppl 2010, 11:49-54.
• [10]Galloway S, Pallebage-Gamarallage MM, Takechi R, Jian L, Johnsen RD, Dhaliwal SS, Mamo JC: Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance. Lipids Health Dis 2008, 7:15. BioMed Central Full Text
• [11]Galloway S, Jian L, Johnsen R, Chew S, Mamo JC: beta-amyloid or its precursor protein is found in epithelial cells of the small intestine and is stimulated by high-fat feeding. J Nutr Biochem 2007, 18:279-284.
• [12]Galloway S, Takechi R, Pallebage-Gamarallage MM, Dhaliwal SS, Mamo JC: Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine. Lipids Health Dis 2009, 8:46. BioMed Central Full Text
• [13]Inoue N, Ohara Y, Fukai T, Harrison DG, Nishida K: Probucol improves endothelial-dependent relaxation and decreases vascular superoxide production in cholesterol-fed rabbits. Am J Med Sci 1998, 315:242-247.
• [14]Burgess BL, McIsaac SA, Naus KE, Chan JY, Tansley GH, Yang J, Miao F, Ross CJ, van Eck M, Hayden MR, van Nostrand W, van Nostrand W, St. George-Hyslop P, Westaway D, Wellington CL: Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer’s disease mouse models with abundant A beta in plasma. Neurobiol Dis 2006, 24:114-127.
• [15]van Greevenbroek MM, de Bruin TW: Chylomicron synthesis by intestinal cells in vitro and in vivo. Atherosclerosis 1998, 141(Suppl 1):S9-S16.
• [16]Russell JC, Graham SE, Amy RM, Dolphin PJ: Cardioprotective effect of probucol in the atherosclerosis-prone JCR:LA-cp rat. Eur J Pharm 1998, 350:203-210.
• [17]Poirier J, Panisset M: Apolipoprotein E: A novel therapeutic target for the treatment of Alzheimer’s disease. Adv Behav Biol 2002, 51:39-43.
• [18]Pallebage-Gamarallage M, Lam V, Takechi R, Galloway S, Clark K, Mamo J: Restoration of dietary-fat induced blood–brain barrier dysfunction by anti-inflammatory lipid-modulating agents. Lipids Health Dis 2012, 11:117. BioMed Central Full Text
• [19]Ghribi O, Golovko MY, Larsen B, Schrag M, Murphy EJ: Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J Neurochem 2006, 99:438-449.
• [20]Elsegood CL, Mamo JC: An investigation by electron microscopy of chylomicron remnant uptake by human monocyte-derived macrophages. Atherosclerosis 2006, 188:251-259.
• [21]Takechi R, Galloway S, Pallebage-Gamarallage MM, Johnsen RD, Mamo JC: Three-dimensional immunofluorescent double labelling using polyclonal antibodies derived from the same species: enterocytic colocalization of chylomicrons with Golgi apparatus. Histochem Cell Biol 2008, 129:779-784.